Ex vivo differentiation of natural killer cells from human umbilical cord blood CD34 + progenitor cells

Cell Communication and Adhesion

Volumn 18, Issue 3, 2011, Pages 45-55

  Pinho, Maria João ^a   Punzel, Michael ^b   Sousa, Mrio ^a,c   Barros, Alberto ^a,d  

^a University of Porto   (Portugal)

^b Center for Bone Marrow and Stem Cell Donation   (Germany)

^c UNIVERSITY OF PORTO   (Portugal)

^d Center for Reproductive Genetics ABarros   (Portugal)

Author keywords

Ex vivo culture; Immunotherapy; Natural Killer cells; NK receptors

Indexed keywords

CD34 ANTIBODY; IMMUNOGLOBULIN RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2A;

ARTICLE; CELL DIFFERENTIATION; CYTOTOXICITY; EX VIVO STUDY; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; UMBILICAL CORD BLOOD;

ANIMALS; ANTIGENS, CD34; ANTIGENS, CD56; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CULTURE MEDIA, CONDITIONED; FEEDER CELLS; FETAL BLOOD; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELLS; HUMANS; KILLER CELLS, NATURAL; MICE; RECEPTORS, NATURAL KILLER CELL;

EID: 80053238161     PISSN: 15419061     EISSN: 15435180     Source Type: Journal    
DOI: 10.3109/15419061.2011.610911     Document Type: Article

References (31)

1. Borrego F, Kabat J, Kim DK, Lieto L, Maasho K, Pena J, Solana R, and Coligan JE (2002).Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells.Mol Immunol.38: 637-60 (Pubitemid 34168194)
2. Borrego F, Ulbrecht M, Weiss EH, Coligan JE, and Brooks AG (1998).Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis.J Exp Med.187: 813-818 (Pubitemid 28115198)
3. Briard D, Brouty-Boye D, Azzarone B, and Jasmin C (2002).Fibroblasts from human spleen regulate NK cell differentiation from blood CD34(+) progenitors via cell surface IL-15 J Immunol.168 : 4326-4332 (Pubitemid 34441332)
4. Brooks AG, Posch PE, Scorzelli CJ, Borrego F, and Coligan JE (1997).NKG2A complexed with CD94 defines a novel inhibitory natural killer cell receptor.J Exp Med.185: 795-800 (Pubitemid 27098164)
5. Byrd A, Hoffmann SC, Jarahian M, Momburg F, and Watzl C (2007).Expression analysis of the ligands for the Natural Killer cell receptors NKp30 and NKp44 PLoS One.2: e1339
6. Caligiuri MA, Zmuidzinas A, Manley TJ, Levine H, Smith K A, and Ritz J (1990).Functional consequences of interleukin 2 receptor expression on resting human lymphocytes.Identification of a novel natural killer cell subset with high affinity receptors.J Exp Med.171: 1509-1526 (Pubitemid 20167547)
7. Carayol G, Robin C, Bourhis JH, Bennaceur-Griscelli A, Chouaib S, Coulombel L, and Caignard A (1998).NK cells differentiated from bone marrow, cord blood and peripheral blood stem cells exhibit similar phenotype and functions.Eur J Immunol.28: 1991-2002 (Pubitemid 28271716)
8. Colucci F, Caligiuri MA, and Di Santo JP (2003).What does it take to make a natural killer? Nat Rev Immunol.3: 413-425 (Pubitemid 37323201)
9. + cytotoxic cells from human umbilical cord blood.Exp Hematol.29: 104-113 (Pubitemid 32054772)
10. Cooper MA, Fehniger TA, and Caligiuri MA (2001).The biology of human natural killer-cell subsets.Trends Immunol.22 : 633-640 (Pubitemid 33043908)
11. Farag SS and Caligiuri MA (2006).Human natural killer cell development and biology.Blood Rev.20: 123-137 (Pubitemid 43786166)
12. Figueiredo C, Seltsam A, and Blasczyk R (2009).Permanent silencing of NKG2A expression for cell-based therapeutics.J Mol Med.87: 199-210
13. Garcia-Lora A, Algarra I, and Garrido F (2003).MHC class I antigens, immune surveillance, and tumor immune escape.J Cell Physiol.195: 346-355 (Pubitemid 36529863)
14. Grzywacz B, Kataria N, Sikora M, Oostendorp RA, Dzierzak EA, Blazar BR, Miller JS, and Verneris MR (2006).Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells.Blood.108: 3824-3833 (Pubitemid 44864565)
15. Hallett WH and Murphy WJ (2006).Positive and negative regulation of Natural Killer cells: therapeutic implications.Semin Cancer Biol.16: 367-382 (Pubitemid 44311501)
16. Iizuka K, Chaplin DD, Wang Y, Wu Q, Pegg LE, Yokoyama WM, and Fu YX (1999).Requirement for membrane lymphotoxin in natural killer cell development.Proc Natl Acad Sci U S A.96: 6336-6340 (Pubitemid 29256666)
17. + cells.Stem Cells Dev.16: 1043-1051
18. Kato N, Tanaka J, Sugita J, Toubai T, Miura Y, Ibata M, Syono Y, Ota S, Kondo T, Asaka M, and Imamura M (2007).Regulation of the expression of MHC class I-related chain A, B (MICA, MICB) via chromatin remodeling and its impact on the susceptibility of leukemic cells to the cytotoxicity of NKG2D-expressing cells.Leukemia.21: 2103-2108 (Pubitemid 47423800)
19. Lanier LL (2008).Up on the tightrope: natural killer cell activation and inhibition.Nat Immunol.9: 495-502 (Pubitemid 351560518)
20. Lanier LL, Testi R, Bindl J, and Phillips JH (1989).Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule.J Exp Med.169 : 2233-2238 (Pubitemid 19162980)
21. Lewis ID and Verfaillie CM (2000).Multi-lineage expansion potential of primitive hematopoietic progenitors: superiority of umbilical cord blood compared to mobilized peripheral blood.Exp Hematol.28: 1087-1095
22. Miller JS and Mccullar V (2001).Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2 Blood.98: 705-713
23. Moore KA, Ema H and Lemischka IR (1997).In vitro maintenance of highly purified, transplantable hematopoietic stem cells.Blood.89: 4337-4347 (Pubitemid 27260241)
24. Moretta L, Biassoni R, Bottino C, Cantoni C, Pende D, Mingari MC, and Moretta A (2002).Human NK cells and their receptors.Microbes Infect.4: 1539-1544 (Pubitemid 36050823)
25. + hematopoietic progenitor cells.Blood.87: 2632-2640 (Pubitemid 26102211)
26. Nagler A, Lanier LL, and Phillips JH (1990).Constitutive expression of high affinity interleukin 2 receptors on human CD16-natural killer cells in vivo.J Exp Med.171: 1527-1533 (Pubitemid 20167548)
27. Orange JS and Ballas ZK (2006).Natural killer cells in human health and disease.Clin Immunol.118: 1-10 (Pubitemid 43012040)
28. Orange JS, Fassett MS, Koopman LA, Boyson JE, and Strominger JL (2002).Viral evasion of natural killer cells.Nat Immunol.3: 1006-1012 (Pubitemid 35363650)
29. Papamichail M, Perez SA, Gritzapis AD and Baxevanis CN (2004).Natural killer lymphocytes: biology, development, and function.Cancer Immunol Immunother.53: 176-186 (Pubitemid 38328040)
30. Robertson MJ and Ritz J (1990).Biology and clinical relevance of human natural killer cells.Blood.76: 2421-2438
31. Robertson MJ, Soiffer RJ, Wolf SF, Manley TJ, Donahue C, Young D, Herrmann SH, and Ritz J (1992).Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF.J Exp Med.175: 779-788